* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Establishing a Territory Goal/Move 2
Cytokinesis wikipedia , lookup
Cell growth wikipedia , lookup
Extracellular matrix wikipedia , lookup
Cell encapsulation wikipedia , lookup
Organ-on-a-chip wikipedia , lookup
Cell culture wikipedia , lookup
List of types of proteins wikipedia , lookup
Tissue engineering wikipedia , lookup
Epigenetics in stem-cell differentiation wikipedia , lookup
Somatic cell nuclear transfer wikipedia , lookup
Activity 1: Communicative Goals Passage Goal/Move 1: Establishing a Territory Goal/Move 2: Identifying a Niche Goal/Move 3: Addressing the Nice Cell source is a major issue for tissue engineering and regenerative medicine. An exciting breakthrough in stem cell biology is that adult somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by the activation of a limited number of genes1. The iPSCs derived from somatic cells make it possible for patient-specific cell therapies, which bypasses immune rejection issues and ethic concerns of using embryonic stem cells (ESCs) as a cell source. The unlimited expansion potential of iPSCs also makes them a valuable cell source for tissue engineering. However, to use iPSCs as a cell source, many important issues remain to be addressed, such as the differences among various iPSC lines in differentiation and expansion and the appropriate differentiation stage of the cells for specific tissue engineering applications. Neural crest stem cells can differentiate into cell types of all three germ layers, and represent a valuable model system to investigate the differentiation and therapeutic potential of stem cells2-4. Here we derived neural crest stem cells from human iPSCs and ESCs to determine the variation among iPSC lines, and used the model of peripheral nerve regeneration to investigate the differentiation and therapeutic potential of neuronal crest stem cells in vivo.